View in EDS PDF Full Text

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.

Saved in:
Bibliographic Details
Title: Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
Authors: Sho, Takuya1 (AUTHOR), Suda, Goki1 (AUTHOR) gsudgast@pop.med.hokudai.ac.jp, Yamamoto, Yoshiya2 (AUTHOR), Furuya, Ken3 (AUTHOR), Baba, Masaru3 (AUTHOR), Ogawa, Koji1 (AUTHOR), Kubo, Akinori1 (AUTHOR), Tokuchi, Yoshimasa1 (AUTHOR), Fu, Qingjie1 (AUTHOR), Yang, Zijian1 (AUTHOR), Kimura, Megumi1 (AUTHOR), Kitagataya, Takashi1 (AUTHOR), Maehara, Osamu4 (AUTHOR), Ohnishi, Shunsuke4 (AUTHOR), Nakamura, Akihisa1 (AUTHOR), Yamada, Ren1 (AUTHOR), Ohara, Masatsugu1 (AUTHOR), Kawagishi, Naoki1 (AUTHOR), Natsuizaka, Mitsuteru1 (AUTHOR), Nakai, Masato1 (AUTHOR)
Source: Cancers. Aug2022, Vol. 14 Issue 16, p3938. 18p.
Database: Academic Search Ultimate
Description
ISSN:20726694
DOI:10.3390/cancers14163938